Homocysteine: Its Possible Emerging Role in At-Risk Population Groups
Open Access
- 20 February 2020
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (4) , 1421
Abstract
Increased plasma homocysteine is a risk factor for several pathological disorders. The present review focused on the role of homocysteine (Hcy) in different population groups, especially in risk conditions (pregnancy, infancy, old age), and on its relevance as a marker or etiological factor of the diseases in these age groups, focusing on the nutritional treatment of elevated Hcy levels. In pregnancy, Hcy levels were investigated in relation to the increased risk of adverse pregnancy outcomes such as small size for gestational age at birth, preeclampsia, recurrent abortions, low birth weight, or intrauterine growth restriction. In pediatric populations, Hcy levels are important not only for cardiovascular disease, obesity, and renal disease, but the most interesting evidence concerns study of elevated levels of Hcy in autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD). Finally, a focus on the principal pathologies of the elderly (cardiovascular and neurodegenerative disease, osteoporosis and physical function) is presented. The metabolism of Hcy is influenced by B vitamins, and Hcy-lowering vitamin treatments have been proposed. However, clinical trials have not reached a consensus about the effectiveness of vitamin supplementation on the reduction of Hcy levels and improvement of pathological condition, especially in elderly patients with overt pathologies, suggesting that other dietary and non-dietary factors are involved in high Hcy levels. The importance of novel experimental designs focusing on intra-individual variability as a complement to the typical case–control experimental designs and the study of interactions between different factors it should be emphasized.Keywords
This publication has 194 references indexed in Scilit:
- Effectiveness of Methylcobalamin and Folinic Acid Treatment on Adaptive Behavior in Children with Autistic Disorder Is Related to Glutathione Redox StatusAutism Research and Treatment, 2013
- Defective Homocysteine Metabolism: Potential Implications for Skeletal Muscle MalfunctionInternational Journal of Molecular Sciences, 2013
- Folic acid and vitamin B12 supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trialNutrition Research, 2013
- Vitamin B12, Folate, Homocysteine, and Bone Health in Adults and Elderly People: A Systematic Review with Meta-AnalysesJournal of Nutrition and Metabolism, 2013
- The potential role of the antioxidant and detoxification properties of glutathione in autism spectrum disorders: a systematic review and meta-analysisNutrition & Metabolism, 2012
- Homocysteine is transported by the microvillous plasma membrane of human placentaJournal of Inherited Metabolic Disease, 2010
- Efficacy of Homocysteine-Lowering Therapy With Folic Acid in Stroke PreventionStroke, 2010
- High levels of homocysteine and low serum paraoxonase 1 arylesterase activity in children with autismLife Sciences, 2006
- Neural tube defects and maternal biomarkers of folate, homocysteine, and glutathione metabolismBirth Defects Research Part A: Clinical and Molecular Teratology, 2006
- Homocysteine and Vitamin B12 Status Relate to Bone Turnover Markers, Broadband Ultrasound Attenuation, and Fractures in Healthy Elderly PeopleJournal of Bone and Mineral Research, 2005